BioInvent International AB (publ) BOVNF
Set alert
0.44 USD -0.17 -27.16%
As of Nov 2, 9:59 AM ET
0.4441 Day range 0.5486
0.4441 52-week range 3.29
- YTD
- -86.50%
- 1 year
- -86.50%
- Open
- 0.5486
- Prev close
- 0.6097
- Mkt cap
- 29.22M
- Vol
- 7.00K
- Avg vol
- 78
- EPS
- -0.79
- P/E
- 0.00
More statistics
- Low
- 0.4441
- High
- 0.5486
News
- BioInvent International AB (publ) (BOVNF) Q3 2026 Earnings Call Transcript
- BioInvent To Present BI-1808 Data in Platinum-Resistant Recurrent Ovarian Cancer at ESMO 2026
- BioInvent International AB Announces that its CFO will Retire in 2027
- BioInvent International AB (publ) (BOVNF) Discusses Ovarian Cancer Treatment Landscape and TNFR2-Targeted Therapies in Solid Tumors Transcript
- BioInvent to Host Virtual KOL Event to Discuss BI-1808 for the Treatment of Ovarian Cancer, on May 27, 2026
- Resolutions at BioInvent's Annual General Meeting 2026
- BioInvent to Host Two Key Opinion Leader Events Highlighting Progress Across Oncology Portfolio
- BioInvent International AB: Interim Report January - March 2026
- BioInvent to Present Data of BI-1808 Plus KEYTRUDA(R) (Pembrolizumab) in Recurrent Ovarian Cancer at the 2026 ASCO Annual Meeting
- BioInvent International AB Publishes Annual Report 2025
Your note
Sign in to keep a note on BOVNF — it syncs with the Stock Master app.